Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Dynamic Business Location.

Pfizer acquisition of Baxter vaccines is concluded

Pfizer‘s acquisition of Baxter’s authorized vaccines took place at the end of 2014, with Pfizer investing a total of USD 635 million (EUR 473 million). The Baxter production site in Orth an der Donau, which currently employs a workforce of 230 people to produce a vaccine against meningococcal C and FSME, was also part of the acquisition. The integration of the product portfolio purchased from Baxter International Inc. in December 2014 has now been concluded. Since May 1, 2015, Pfizer Austria has been the marketing authorization holder of the vaccines NeisVac-C(R) and FSME-IMMUN(R).

"With the plant in Austria, we have a clear commitment to the business location Austria“, says Robin Rumler, Managing Director of Pfizer Austria. As the marketing authorization holder, Pfizer is now in possession of complete responsibility for all authorization obligations, including activities in connection with pharmacovigilance, order management, sales and invoicing, inquiries on medical data and product complaints relating to the meningococcal C and FSME vaccines. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Business Location Austria

    24.09.2019, Bucharest, Romania

  • Business Location Austria

    25.09.2019, Cluj-Napoca, Romania

Austria Map

Find the perfect location for your company

Austria is well known for its social stability and excellent labor relations where strikes are measured only in seconds. As a global player, reliable deliveries are a top priority for us.

Opel Austria

Logo
More testimonials

news from the business location Austria

ERC Starting Grant for molecular biologist in Innsbruck

The molecular biologist Jerome Mertens received a Starting Grant of the European Research Council (ERC) for his research into understanding the molecular and cellular causes of aging, especially brain aging and molecular cell biology of Alzheimer's disease in nerve cells.

Not Only for Startups: The Business Plan as the Road Map to Success

A great idea has been born. The product the world is waiting for has been invented. Actually, nothing can seemingly go wrong. At least one would be inclined to think so. However, the best idea or invention is worthless without a business plan to successfully bring the idea down to earth. Here you will find out what you should take into consideration when drawing up a business plan.

More news All blog posts